Sanofi 's head of global research and development Elias Zerhouni feels the outside world – meaning analysts and investors – have yet to fully appreciate the pipeline progress and future promise generated by his ongoing revamp of the French group's R&D process, but he is confident that will soon happen, helped by further expected success developing multi-specific therapies.
Sanofi R&D Chief Zerhouni: How I'm Doing More With Less
Elias Zerhouni says Sanofi's ongoing R&D revamp has produced improved innovative results with controlled spending, in part by emphasizing cutting-edge product development ahead of research.
